Cargando…

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

BACKGROUND: Gliomas are one of the most lethal cancers in the human central nervous system. Despite clinical treatment advancements, the prognosis of patients with glioma remains poor. KDM2B is a histone lysine demethylase, which has been observed in multiple tumors. But the concrete role of KDM2B i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yiwei, Zang, Jin, Zhang, Dongyong, Sun, Zhenxiang, Qiu, Bo, Wang, Xiaojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764301/ https://www.ncbi.nlm.nih.gov/pubmed/29386904 http://dx.doi.org/10.2147/OTT.S149833

Ejemplares similares

Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
por: Shigekawa, Yoshinobu, et al.
Publicado: (2018)

Scinderin Is a Novel Oncogene for Its Correlates with Poor Prognosis, Immune Infiltrates and Matrix Metalloproteinase-2/9 (MMP2/9) in Glioma
por: Wang, Yiwei, et al.
Publicado: (2022)

KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck
por: Huang, Donghai, et al.
Publicado: (2018)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas
por: Yu, Shoukai
Publicado: (2022)

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)

Co-overexpression of RIOK1 and AKT1 as a prognostic risk factor in glioma
por: Wang, Yiwei, et al.
Publicado: (2021)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)

DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression
por: Chen, Xi, et al.
Publicado: (2022)

BAG2 Overexpression Correlates with Growth and Poor Prognosis of Esophageal Squamous Cell Carcinoma
por: Hong, Ying-Cai, et al.
Publicado: (2018)

MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer
por: Liu, Longyang, et al.
Publicado: (2019)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
por: Zhu, Huaxin, et al.
Publicado: (2022)

Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas
por: Guo, Geng, et al.
Publicado: (2015)

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas
por: Guan, Xiudong, et al.
Publicado: (2018)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
por: Lu, Wenjie, et al.
Publicado: (2020)

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
por: Li, Sibo, et al.
Publicado: (2022)

Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma
por: Sun, Ying, et al.
Publicado: (2017)

Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
por: Yun, Sumi, et al.
Publicado: (2018)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

Correlation of microrna-372 upregulation with poor prognosis in human glioma
por: Li, Gang, et al.
Publicado: (2013)

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

Overexpression of leptin receptor in human glioblastoma: Correlation with vasculogenic mimicry and poor prognosis
por: Han, Guosheng, et al.
Publicado: (2017)

Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis
por: Wu, Changwu, et al.
Publicado: (2019)

Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer
por: Wang, Bingwei, et al.
Publicado: (2019)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer
por: Lou, Jiayan, et al.
Publicado: (2022)

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020)

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015)

Decreased let-7b is associated with poor prognosis in glioma
por: Zhang, Wanzeng, et al.
Publicado: (2019)

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
por: Luo, Dingyuan, et al.
Publicado: (2017)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_shc9tm7nml3ksud1a3nkub092p